It has been reported that a few cases of never-smokers SCLC patients harboring epidermal growth factor receptor (EGFR) mutations, and responded to EGFR tyrosine kinase inhibitors (TKIs) (6). This evidence concerns the gene EGFR and small cell lung carcinoma.